App-Quantinova.ai

Targeting optimal metabolic parameters in type 1 diabetes and concomitant coeliac disease: an extra challenge

Tom Cotter - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Long-term use of insulin pump vs pens in treating young children with type 1 diabetes

Fawzia Alkhalaf - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Prandial Insulin

Effect of liraglutide 1.8 mg in patients with non-controlled type 2 diabetes mellitus at an endocrinology clinic: LIED-2 Study

Alvaro A Herrera - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Liraglutide

Correlation of left ventricular hypertrophy and left ventricular diastolic dysfunction with HbA1c in newly diagnosed type 2 diabetics

Syed Mohd Razi - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular diastolic dysfunction

N/A

The frequency of fall and risk factors in elderly patients with type 2 diabetes

Fulden Sarac - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Type 2 diabetes mellitus

N/A

Microalbuminuria in children and adolescents with type 1 diabetes mellitus: predictive factors

Ricardo Monteiro - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Phenotype-directed personalisation of therapy in type 2 diabetes mellitus patients and criteria of prescription

Viktors Snigirovs - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Glucogenic hepatopathy: a rare and underdiagnosed condition in type 1 diabetes

Demet Ozgil Yetkin - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Fatty Liver Disease

N/A

Achievement of recommended glucose, lipid, and blood pressure targets in patients with type 2 diabetes mellitus

Ines Slim - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Staphylococcus aureus nasal carriage and related risk factors in diabetic foot patients

Mustafa Altay - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic foot

Insulin oral

The role of fetuin A as a biomarker of atherosclerosis and its relation to type 2 diabetes

Rania Sayed - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Arterial stiffness

N/A

Association of plasma fetuin-A levels and peripheral vascular disease in type 2 diabetic patients

Rania Sayed - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral artery disease

N/A

Glycaemic variability in pregnant women with gestational diabetes

Selda Celik - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Gestational Diabetes

N/A

Particular characteristics of breath during night sleep in type 1 diabetes patients

Tatsiana Mokhort - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Type 1 diabetes mellitus

N/A

Obstructive sleep apnoea, incident type 2 diabetes mellitus, and cardiovascular risk

M Mendez-Bailon - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Simultaneous pancreaskidney transplantation effect on stabilisation/progression of diabetic complications in patients with type 1 diabetes

Alexandra Glazunova - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Microvascular complications of diabetes 1

N/A

Lixisenatide clinical experience on patients with type 2 diabetes and obesity in Endocrinology Offices

Maria Teresa Muros de Fuentes - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Lixisenatide

Evaluation series on safety and efficacy of nutritional supplements (ESSENS) in newly diagnosed hyperglycaemia

Sanjay Kalra - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Diabetes

Metformin Hydrochloride

Association between cardiovascular disease and microvascular complications in diabetic patients

Elena Garcia Fernandez - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Continuous glucose monitoring systems and the improvement in hypoglycaemic awareness post-islet transplantation: a single-centre cohort study

Shareen Forbes - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

4759 Abstracts